Fujirebio US, Inc.
Malvern, PA Fujirebio Diagnostics, Inc. Part of Abbott Laboratories
- UEI
- QLBVMG7KJ3W5
- CAGE
- 47VE1
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Abbott Laboratories
Parent
EF9EAJ1MF6U3
- Fujirebio US, Inc. QLBVMG7KJ3W5
-
Abbott Laboratories
Parent
EF9EAJ1MF6U3
- SAM.gov registration date
- Physical address
- 205 Great Valley Pkwy, Malvern, PA 19355, USA
- Website
- fujirebio.com
- Founded
- 1950
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Assay kits for lumipulse instrument. | National Institute on Drug Abuse | $97,757 | |
| Plasma reagents, calibrators and controls. | National Institute on Drug Abuse | $190,372 | |
| Inno-LIA HIV i/II score | CDC Pittsburgh | $24,070 | |
| Inno-LIA HCV score | CDC Pittsburgh | $4,000 | |
| Lumipulse immunoassay system | Veterans Integrated Service Network 20 | $118,942 |
About Fujirebio US, Inc.
Fujirebio US, Inc. is a for-profit, corporate entity registered in SAM.gov since 2005, specializing in medical diagnostics manufacturing and equipment production. As a child entity with a location in Malvern, Pennsylvania, the company focuses on developing advanced medical testing technologies and diagnostic solutions for healthcare and research institutions. The organization is a manufacturer of goods that provides specialized medical diagnostic equipment, reagents, assay kits, and related scientific instruments to federal government agencies.
The company has secured multiple federal contract awards primarily from healthcare-related agencies, including the National Institute on Aging, Centers for Disease Control and Prevention, Department of Veterans Affairs, and National Cancer Institute. These contracts, typically structured as purchase orders, have ranged from $3,999.70 to $190,372.20 and cover a diverse range of diagnostic products. Specific products include INNO-LIA HIV I/II SCORE tests, INNO-LIA HCV SCORE tests, Lumipulse immunoassay systems, plasma reagents, calibrators, controls, and assay kits for quantifying biomarkers related to Alzheimer's disease. None of the contracts have had specific set-aside designations, and they have consistently been awarded as direct purchases to support medical research, public health monitoring, and clinical studies. The contracts demonstrate Fujirebio's expertise in providing cutting-edge diagnostic technologies across various medical domains, with a particular emphasis on neurological disease research and infectious disease testing.
Quick answers
What is Fujirebio US, Inc.'s UEI?
Fujirebio US, Inc.'s Unique Entity ID (UEI) in SAM.gov is QLBVMG7KJ3W5.
What is Fujirebio US, Inc.'s CAGE code?
Fujirebio US, Inc.'s CAGE code is 47VE1.
What is Fujirebio US, Inc.'s primary NAICS code?
Fujirebio US, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Fujirebio US, Inc. located?
Fujirebio US, Inc.'s physical address in SAM.gov is 205 Great Valley Pkwy, Malvern, PA 19355, USA.
Is Fujirebio US, Inc. registered in SAM.gov?
Yes. Fujirebio US, Inc.'s SAM.gov registration is active through December 16, 2026.
Who is Fujirebio US, Inc.'s parent company?
Fujirebio US, Inc. is part of Abbott Laboratories.
What is Fujirebio US, Inc.'s most recent federal award?
Fujirebio US, Inc.'s most recent federal contract award is Assay kits for lumipulse instrument (75N95025P00106), from National Institute on Drug Abuse, on February 20, 2025.
On GovTribe
See Fujirebio US, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors